CA 2024 * | 681 M 623 M | CA 2025 * | 836 M 765 M | Capitalisation | 3,26 Md 2,98 Md |
---|---|---|---|---|---|
Résultat net 2024 * | -109 M -99,73 M | Résultat net 2025 * | -5 M -4,57 M | VE / CA 2024 * | 4,49 x |
Trésorerie nette 2024 * | 199 M 182 M | Trésorerie nette 2025 * | 306 M 280 M | VE / CA 2025 * | 3,53 x |
PER 2024 * |
-28,2
x | PER 2025 * |
592
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 52,37% |
Dernier transcript sur HUTCHISON CHINA MED.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Wei Guo Su
CEO | Chief Executive Officer | 66 | 01/01/05 |
Chig Fung Cheng
DFI | Director of Finance/CFO | 57 | 01/07/08 |
Michael Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/01/22 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chi Keung To
CHM | Chairman | 72 | 01/01/00 |
Graeme Jack
BRD | Director/Board Member | 73 | 01/03/17 |
Dan Eldar
BRD | Director/Board Member | 70 | 01/08/16 |
Varia. 1 janv. | Capi. | |
---|---|---|
+26,47% | 664 Md | |
+27,86% | 567 Md | |
-6,33% | 354 Md | |
+19,35% | 330 Md | |
+4,23% | 286 Md | |
+13,55% | 234 Md | |
+4,77% | 199 Md | |
-10,18% | 196 Md | |
-4,04% | 148 Md |